-
公开(公告)号:EP3831409A1
公开(公告)日:2021-06-09
申请号:EP19844718.7
申请日:2019-07-31
IPC分类号: A61K45/00 , A61K31/711 , A61K45/06 , A61P19/02 , A61P19/08 , A61P19/10 , A61P29/00 , A61P35/00 , A61P37/02 , A61P43/00 , C12N9/99 , C12N15/113 , C12Q1/48 , C12Q1/6809 , G01N33/15 , G01N33/50
摘要: The present disclosure addresses the problem of providing a novel therapeutic agent, for cartilage disease, that has cartilage-regenerating action. Because substances having SIK2 inhibitory action have chondrocyte-differentiation-inducing action, a therapeutic agent formed so as to contain a substance having SIK2-inhibitory action is useful as a therapeutic agent, having cartilage-regenerating action, for cartilage damage or cartilage diseases such as osteoarthritis.